News

Clinical Trials Arena22h

Nanoscope’s Stargardt disease gene therapy improves vision in Phase II

The Phase II STARLIGHT study (NCT05417126) found that a single intravitreal injection of gene-agnostic MCO-010 in six ...
Clinical Trials Arena22h

CytomX to continue Phase I ADC trial despite patient death

CytomX's Phase I trial of ADC CX-2051 in colorectal cancer will continue based on a decision made by a safety committee ...